Dementia and Alzheimer Disease

Epilepsy

Headache and Migraine

Movement Disorders

Multiple Sclerosis

Neuromuscular

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

eNewsletter

Print Subscription

Articles

While specialists still debate the diagnostics of impaired cognition, the identification of patients at the earliest stages is beginning to be met through new biomarkers and available assays.

Changes in the Diagnostic Process of Alzheimer Disease: A New Era of Blood-Based Approaches

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 8, 2023.

NeurologyLive® Friday 5 — December 8, 2023

Videos

The assistant professor of neurology at the University of Virginia talked about findings from a comprehensive study on mild cognitive impairment and epilepsy, which was recently presented at AES 2023. [WATCH TIME: 5 minutes] 


Insights From Comprehensive Research on Epilepsy and Cognitive Decline: Ifrah Zawar, MD

Catch up on any of the neurology news headlines you may have missed over the course of November 2023, compiled all into one place by the NeurologyLive® team.

FDA Action Update, November 2023: Acceptance, Clearance, and Hold

, has been with the team since October 2019. Follow him on Twitter 

The system vice chair for the department of neurology at Allegheny Health Network talked about the latest preventive and acute treatment options for patients with migraine as well as the progress of research in recent months. [WATCH TIME: 3 minutes] 

Looking Back on the Latest Advancements in Acute Migraine Treatment: Andrea S. Synowiec, DO, FAAN

Division director of epilepsy and associate professor of neurology at The Ohio State University Wexner Medical Center.

The division director of epilepsy and associate professor of neurology at The Ohio State University Wexner Medical Center talked about the impact of ongoing seizures in patients with drug-resistant epilepsy and the importance of education for emerging opportunities in epilepsy care. [WATCH TIME: 3 minutes] 

Emphasizing Patient Conversations and Treatment Opportunities for Seizure Management: Danielle Becker, MD, MS, FAES

The division director of epilepsy and associate professor of neurology at The Ohio State University Wexner Medical Center discussed the profound repercussion of ongoing seizures for patients with epilepsy which is to be presented at AES 2023 in SK Life Science’s symposium. [WATCH TIME: 5 minutes] 

Exploring the Hidden Burdens of Persistent Seizures for Patients: Danielle Becker, MD, MS, FAES

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

Spotlight

Narcolepsy

NMOSD

Ataxia

Parkinson Disease

AES 2023

AANEM 2023

CTAD 2023

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

1rem

Authors

Chief scientific officer at Athira Pharma.

The chief scientific officer at Athira Pharma talked about new preclinical results presented at the 2023 NEALS Annual Meeting on the investigational therapy ATH-1105 for patients with amyotrophic lateral sclerosis. [WATCH TIME: 5 minutes] 

Targeting Neurotrophic Factors and Preclinical Results of ALS Agent ATH-11055: Kevin Church, PhD